92.72

0.70% -0.60

Biontech Se Adr (BNTX)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt BNTX? Forum Prognose Dividendenhistorie

Schlusskurs vom Vortag:

$93.32

Offen:

$91.21

24-Stunden-Volumen:

534.97K

Relative Volume:

0.69

Marktkapitalisierung:

$21.67B

Einnahmen:

$3.30B

Nettoeinkommen (Verlust:

$-501.07M

KGV:

-43.85

EPS:

-2.1146

Netto-Cashflow:

$1.03B

1W Leistung:

-2.86%

1M Leistung:

-16.93%

6M Leistung:

-22.65%

1J Leistung:

+2.08%

1-Tages-Spanne:

$89.68

$93.97

1-Wochen-Bereich:

$85.55

$96.01

52-Wochen-Spanne:

$76.53

$131.49

Biontech Se Adr Stock (BNTX) Company Profile

Firmenname

Biontech Se Adr

Sektor

Healthcare (1161)

Branche

Biotechnology (676)

Telefon

Adresse

Mitarbeiter

Twitter

@BioNTech_Group

Nächster Verdiensttermin

2025-03-10

Neueste SEC-Einreichungen

BNTX's Discussions on Twitter

Vergleichen Sie BNTX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BNTX Biontech Se Adr	92.62	21.67B	3.30B	-501.07M	1.03B	-2.1146
VRTX Vertex Pharmaceuticals Inc	485.59	125.55B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	621.35	67.78B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	589.34	36.24B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	260.88	33.99B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	264.41	28.77B	3.81B	-644.79M	-669.77M	-6.24

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-13	Eingeleitet	Citigroup	Buy
2025-01-10	Eingeleitet	Truist	Buy
2024-12-11	Eingeleitet	Wells Fargo	Overweight
2024-12-02	Bestätigt	BMO Capital Markets	Outperform
2024-11-19	Eingeleitet	Berenberg	Buy
2024-11-19	Hochstufung	Evercore ISI	In-line → Outperform
2024-11-08	Hochstufung	Goldman	Neutral → Buy
2024-09-24	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-09-17	Hochstufung	Jefferies	Hold → Buy
2024-09-16	Hochstufung	JP Morgan	Underweight → Neutral
2024-08-07	Hochstufung	Deutsche Bank	Hold → Buy
2024-08-02	Hochstufung	HSBC Securities	Hold → Buy
2024-05-14	Eingeleitet	Evercore ISI	In-line
2024-02-23	Eingeleitet	BMO Capital Markets	Outperform
2024-01-05	Eingeleitet	Oppenheimer	Perform
2023-12-01	Herabstufung	JP Morgan	Neutral → Underweight
2023-10-16	Herabstufung	HSBC Securities	Buy → Hold
2023-07-14	Eingeleitet	HSBC Securities	Buy
2023-05-17	Hochstufung	Redburn	Neutral → Buy
2022-12-15	Hochstufung	BofA Securities	Neutral → Buy
2022-08-17	Eingeleitet	Cowen	Market Perform
2022-07-13	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-07-06	Fortgesetzt	Canaccord Genuity	Buy
2022-02-01	Hochstufung	Redburn	Sell → Neutral
2021-12-16	Eingeleitet	Morgan Stanley	Equal-Weight
2021-11-10	Hochstufung	H.C. Wainwright	Neutral → Buy
2021-10-22	Eingeleitet	Deutsche Bank	Hold
2021-10-07	Eingeleitet	Jefferies	Hold
2021-08-11	Hochstufung	Bryan Garnier	Neutral → Buy
2021-07-19	Fortgesetzt	Wolfe Research	Outperform
2021-06-16	Herabstufung	Redburn	Neutral → Sell
2021-05-18	Eingeleitet	Goldman	Neutral
2021-05-11	Herabstufung	Bryan Garnier	Buy → Neutral
2020-12-01	Herabstufung	BofA Securities	Buy → Neutral
2020-08-03	Fortgesetzt	Berenberg	Buy
2020-07-21	Hochstufung	BofA Securities	Neutral → Buy
2020-06-30	Herabstufung	H.C. Wainwright	Buy → Neutral
2020-05-19	Hochstufung	H.C. Wainwright	Neutral → Buy
2020-04-28	Herabstufung	BofA/Merrill	Buy → Neutral
2020-03-18	Herabstufung	JP Morgan	Overweight → Neutral
2020-03-09	Eingeleitet	H.C. Wainwright	Neutral
2020-01-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-01-22	Herabstufung	UBS	Buy → Neutral
2019-11-05	Eingeleitet	Wolfe Research	Outperform
2019-11-04	Eingeleitet	Berenberg	Buy
2019-11-04	Eingeleitet	BofA/Merrill	Buy
2019-11-04	Eingeleitet	Canaccord Genuity	Buy
2019-11-04	Eingeleitet	JP Morgan	Overweight
2019-11-04	Eingeleitet	SVB Leerink	Outperform
2019-11-04	Eingeleitet	UBS	Buy

Alle ansehen

Biontech Se Adr Aktie (BNTX) Neueste Nachrichten

Mar 17, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Mar 17, 2025

Mar 11, 2025

BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat - Morningstar

Mar 10, 2025

Jefferies maintains BioNTech stock Buy rating, $149 target - Investing.com India

Mar 10, 2025

Earnings call transcript: BioNTech beats Q4 2024 expectations, stock dips - Investing.com

Mar 10, 2025

BioNTech Surpasses Q4 Revenue Estimates - The Motley Fool

Mar 10, 2025

US Stocks Likely To Open Lower After Trump Hints At Looming Recession: Expert Says Can't Rule Out A Bear Market As Indices Inch Towards Correction Territory - Benzinga

Mar 10, 2025

BioNTech reports Q4 EPS EUR 1.08 vs. EUR 1.88 last year - TipRanks

Mar 10, 2025

Mar 06, 2025

Here's Why Moderna Stock Soared 16% On Wednesday - Barchart

Mar 06, 2025

Here's Why Moderna Stock Soared 16% on Wednesday - Yahoo Finance

Mar 06, 2025

BioNTech SE's RNA-based vaccine for malaria placed on clinical hold by FDA - MSN

Mar 06, 2025

Paramount Group Inc (PGRE) Shares Soar Above 1-Year High - The News Heater

Mar 06, 2025

Mar 05, 2025

Pfizer and BioNTech violated COVID-19 vaccine patent held by Moderna, German court rules - The Globe and Mail

Mar 05, 2025

Mar 04, 2025

BioNTech stock falls after FDA clinical hold on malaria vaccine trial - Investing.com

Mar 04, 2025

Feb 27, 2025

BioNTech SEADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Feb 24, 2025

Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus - Yahoo Finance

Feb 24, 2025

Feb 19, 2025

AASTOCKS Financial NewsBioNTech SE (BNTX) - AASTOCKS.com

Feb 19, 2025

Feb 15, 2025

Are Medical Stocks Lagging Auna S.A. (AUNA) This Year? - MSN

Feb 15, 2025

Feb 13, 2025

What Makes BioNTech (BNTX) a New Buy Stock - Yahoo Finance UK

Feb 13, 2025

Feb 06, 2025